A Research Study on How Semaglutide Works in People With Fatty Liver Disease and Liver Damage
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 69
Summary
- Conditions
- Non Alcoholic Steatohepatitis
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Masking Description: Sponsor staff involved in the clinical trial is masked according to company standard procedures.Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 75 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03987451
- Collaborators
- Not Provided
- Investigators
- Study Director: Clinical Reporting Anchor and Disclosure (1452) Novo Nordisk A/S